Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Zhiqiang, Ou"'
Autor:
Shaomin Chen, Zhifang Ying, Yan Liu, Yuan Li, Yebin Yu, Meilian Huang, Zhuhang Huang, Zhiqiang Ou, Yuyi Liao, Yong Zhang, Guixiu Liu, Weiwei Zhao, Rong Fu, Qiong Shou, Minghuan Zheng, Xueyan Liao, Yingmei Tu, Jon Stek, Jonathan Hartzel, Changgui Li, Jikai Zhang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThis open-label, randomized, phase 3 study in China (V260-074; NCT04481191) evaluated the immunogenicity and safety of concomitant and staggered administration of three doses of an oral, live, pentavalent rotavirus vaccine (RV5) and three dos
Externí odkaz:
https://doaj.org/article/0433b9f021254813a1d04914c2993518
Autor:
Renfeng Fan, Xiaoyuan Huang, Xuanxuan Nian, Zhiqiang Ou, Jian Zhou, Jiayou Zhang, Peiyu Zeng, Wei Zhao, Jinglong Deng, Wei Chen, Shaomin Chen, Kai Duan, Yingshi Chen, Xinguo Li, Jikai Zhang, Xiaoming Yang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1, Pp 1-9 (2022)
To control seasonal influenza epidemics in elders, a quadrivalent, inactivated, split-virion influenza vaccine (IIV4) comprising A and B lineages is produced for young individuals and adults aged ≥60 years. In this phase III, randomized, double-bli
Externí odkaz:
https://doaj.org/article/2db5b883a1db4437beea75b2f71b4480
Autor:
Yuyi Liao, Yuan Li, Rongjuan Pei, Xin Fang, Peiyu Zeng, Renfeng Fan, Zhiqiang Ou, Jinglong Deng, Jian Zhou, Wuxiang Guan, Yuanqin Min, Fei Deng, Hua Peng, Zheng Zhang, Chunyan Feng, Baobao Xin, Jianfeng He, Zhongyu Hu, Jikai Zhang
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 1589-1597 (2021)
Safe and effective vaccines are still urgently needed to cope with the ongoing COVID-19 pandemic. Recently, we developed a recombinant COVID-19 vaccine (V-01) containing fusion protein (IFN-PADRE-RBD-Fc dimer) as antigen verified to induce protective
Externí odkaz:
https://doaj.org/article/479fbed960834ac880ced1ab837942b6
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 9 (2021)
Waste rubber wood (RW) is the castoff of rubber plantation with abundant reservation but without high-value utilization. In this study, cellulose with high purity has been efficiently isolated from waste RW and further processed into cellulose nanocr
Externí odkaz:
https://doaj.org/article/f28b30948f814cd883fcd80cce2e4b17
Publikováno v:
Membranes, Vol 12, Iss 3, p 249 (2022)
Plasma treatment is considered a straightforward, cost-effective, and environmental-friendly technique for surface modification of film materials. In this study, air plasma treatment was applied for performance improvement of pure PVA, cellulose nano
Externí odkaz:
https://doaj.org/article/aca677b331f54831a96e8d7645bff5f4
Autor:
Yajun, Shu, Yebin, Yu, Ying, Ji, Li, Zhang, Yuan, Li, Haiyang, Qin, Zhuhang, Huang, Zhiqiang, Ou, Meilian, Huang, Qiong, Shen, Zehong, Li, Meng, Hu, Chunyun, Li, Gaoxia, Zhang, Jikai, Zhang
Publikováno v:
Vaccine. 40:6947-6955
Human papillomavirus (HPV) infections were the main cause of anogenital cancers and warts. HPV 6/11/16/18 vaccines provide protection against the high-risk types of HPV responsible for 70% of cervical cancers and 90% of genital warts. This randomized
Publikováno v:
Journal of Applied Polymer Science. 140
Publikováno v:
International Journal of Biological Macromolecules. 230:123245
Autor:
Xianliang Liu, Hu Zhang, Haodong Chen, Zhihui Ma, Kaiming Qiao, Longlong Xie, Zhiqiang Ou, Jing Wang, Fengxia Hu, Baogen Shen
Publikováno v:
Applied Thermal Engineering. 221:119827
Autor:
Zhuhang Huang, Jianfeng He, Jiali Su, Zhiqiang Ou, Guixiu Liu, Rong Fu, Qiong Shou, Minghuan Zheng, Thomas Group, Alain Luxembourg, Xueyan Liao, Jikai Zhang
Publikováno v:
Vaccine. 39:760-766
Background The quadrivalent human papillomavirus (qHPV; HPV6/11/16/18) vaccine was approved for use in Chinese women aged 20–45 years in 2017. This Phase 3, open-label study (NCT03493542) aimed to assess immunogenicity and safety of the qHPV vaccin